In vivo topoisomerase I inhibition attenuates the expression of hypoxia-inducible factor 1α target genes and decreases tumor angiogenesis.
Guérin E, Raffelsberger W, Pencreach E, Maier A, Neuville A, Schneider A, Bachellier P, Rohr S, Petitprez A, Poch O, Moras D, Oudet P, Larsen AK, Gaub MP, Guenot D.
Guérin E, et al. Among authors: moras d.
Mol Med. 2012 Feb 10;18(1):83-94. doi: 10.2119/molmed.2011.00120.
Mol Med. 2012.
PMID: 22033674
Free PMC article.